CDH1 and urinary bladder carcinoma: Further investigation suggested that circRIP2-accelerated bladder cancer progression occurred via the miR-1305/TGF-β2/smad3 pathway with downregulation of E-cadherin and upregulation of N-cadherin and vimentin [32].